April 22, 2021 Clinical Research/Diagn. Environ, Ag./Food & Bev Licensing, IP, and Legal Life Science Tools M&A, Partnerships Product Launch

Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) and Kartos Therapeutics, Inc. are pleased to announce a new partnership to co-develop a TP53 companion diagnostic (CDx) based on the content of Illumina’s comprehensive genomic profiling assay, TruSight™ Oncology 500 (TSO 500). This companion diagnostic for multiple hematologic indications will be the first to use TSO 500 with... Read more

April 22, 2021 Clinical Research/Diagn. Liq. Handling & Robotics

Roche purchases shares in tender offer for GenMark Diagnostics, Inc.

Basel, 22 April 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) and GenMark Diagnostics, Inc. today announced that Roche’s wholly owned subsidiary Geronimo Acquisition Corp. has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of GenMark Diagnostics, Inc. (NASDAQ: GNMK)... Read more

April 15, 2021 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Agilent Completes Acquisition of Resolution Bioscience, Expands Role in Fast-growing NGS Market for Precision Oncology

SANTA CLARA, Calif., April 15, 2021  Agilent Technologies, Inc. (NYSE: A) today announced it has completed the acquisition of Resolution Bioscience, a leader in the development and commercialization of next-generation sequencing (NGS)-based precision oncology solutions. Resolution Bioscience complements and expands Agilent’s capabilities in NGS-based cancer diagnostics and provides the company with innovative technology to further... Read more

April 15, 2021 Atomic Spectroscopy Clinical Research/Diagn. Lab Top-10 M&A, Partnerships PAI Top-10

Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization

Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization – Establishes Thermo Fisher as a global leader in the attractive and high growth clinical research services industry – Adds highly complementary services for the company’s fastest growing end market – Offers both meaningful cost and revenue synergies which will further accelerate growth... Read more

April 14, 2021 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development

MINNEAPOLIS, April 14, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced a license agreement for use of a proprietary Bio-Techne antibody by Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, for its therapeutic development pipeline. Bio-Techne is a global life sciences company providing... Read more

April 12, 2021 Clinical Research/Diagn. M&A, Partnerships

Abcam and MEDx extend precision medicine strategic partnership

Cambridge, UK and Shanghai, China, 12 April : Today Abcam (AIM: ABC; NASDAQ: ABCM), a global innovator in life science reagents and tools, and MEDxTranslational Medicine (MEDx), formerly QIAGEN (Suzhou) Translational Medicine Co., Ltd., a company dedicated to developing companion diagnostics and precision medicine, announced the extension of their strategic partnership to include the co-development and commercialization of key... Read more

April 11, 2021 Clinical Research/Diagn. Liq. Handling & Robotics M&A, Partnerships

Diasorin To Acquire Luminex Corporation for USD 37.00 per Share or Approximately USD 1.8 Billion

– Provides Access To Proven Luminex Multiplexing Technology And Molecular Testing Solutions To Be Used In Unique Testing Panels, Generating Critical Mass In The Molecular Diagnostics Space – Sets The Ground For New Partnerships And Business Development Opportunities Through Life Science Offerings – Broadens DiaSorin’s Presence In The U.S. – Accelerates Luminex Technology And Solutions’... Read more

April 6, 2021 Clinical Research/Diagn. M&A, Partnerships

Bio-Techne Completes Acquisition of Asuragen, Inc.

MINNEAPOLIS, April 6, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.  The transaction included initial consideration of $215 million in cash plus contingent consideration of up to $105 million upon the achievement of certain future milestones.  The Asuragen acquisition adds a leading portfolio of best-in-class molecular... Read more

March 25, 2021 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 Life Science Tools Liq. Handling & Robotics Microscopy Product Launch

Thermo Fisher Scientific Completes FDA Listing and Launches the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System for In Vitro Diagnostic Use

Thermo Fisher Scientific Completes FDA Listing and Launches the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System for In Vitro Diagnostic Use Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing CARLSBAD, Calif., March 25, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced the completion of the U.S. Food and Drug... Read more